PMID: 9709387

Wilschanski M, Durie PR
Pathology of pancreatic and intestinal disorders in cystic fibrosis.
J R Soc Med. 1998;91 Suppl 34:40-9., [PubMed]
Sentences
No. Mutations Sentence Comment
84 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9709387:84:42
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9709387:84:60
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9709387:84:49
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9709387:84:35
status: NEW
view ABCC7 p.Gly542* details
The next most common mutations are G542X, G551D, N1303K and W1282X, each of which account for 1% to 2.5% of CF chromosomes throughout the world. Login to comment
85 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9709387:85:36
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9709387:85:114
status: NEW
view ABCC7 p.Gly542* details
Two are missense mutations (G55 ID, N1303K) resulting in an amino acid substitution of the protein product, while G542X and W1 282X are nonsense mutations which give rise to a premature stop codon, leading to the expression of no CFTR or a non-functional truncated protein. Login to comment
88 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9709387:88:31
status: NEW
view ABCC7 p.Trp1282* details
For example, the stop mutation W1282X is present on approximately 50% of Ashkenazi Jewish chromosomes, making it the most common mutation in this particular population. Login to comment
97 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9709387:97:297
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9709387:97:263
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9709387:97:230
status: NEW
view ABCC7 p.Gly542* details
Molecular consequences of cftr gene mutations Several classification systems have been developed in an attempt to define the large number of cftr gene mutations on 43 I =ON 4o0 o 00 4O0 40 40 I II 111 IV V Normal NOmAfl Missnso G542X Missmnse Missense Missense A455E Fremeshift AA dIeIIOn 05510 R117H Allerndve 39soTT AF508 spiRlng Spl$oeJunculon 3849t10kbC4T1717-1G-4A Figure 4 Molecular consequences of cystic fibrosis transmembrane conductance regulator mutations. Login to comment
114 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9709387:114:0
status: NEW
view ABCC7 p.Gly551Asp details
G551D is an example of a class III mutation. Login to comment
117 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9709387:117:249
status: NEW
view ABCC7 p.Arg117His details
Class IV mutations produce protein that reaches the apical membrane, are capable of generating a cAMP regulated apical membrane chloride current, but have altered ionic properties resulting in a reduction in the amount of current; an example is the R117H mutation. Login to comment
119 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9709387:119:102
status: NEW
view ABCC7 p.Ala455Glu details
Class V mutations result in reduced synthesis of normal functioning CFTR due to defective processing (A455E) or aberrant splicing at alternative sites (3849+10kbC-T). Login to comment
152 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9709387:152:280
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9709387:152:234
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 9709387:152:298
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9709387:152:286
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9709387:152:339
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 9709387:152:333
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9709387:152:251
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9709387:152:274
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9709387:152:304
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9709387:152:327
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 9709387:152:363
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9709387:152:240
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9709387:152:462
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 9709387:152:292
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 9709387:152:268
status: NEW
view ABCC7 p.Gly480Cys details
A small number of more Table 1 Classification of cystic fibrosis gene mutation as severe, mild or indeterminate with respect to pancreatic function Severe Mild Variable (classes 1, I/ or 111) (classes IV or V) (classes IV or V) AF508 R117H G85E 1148T R334W 2789+5G-*A G480C R347P G551D A455E R560T P574H N1303K 3849+1 Okb C-+T G542X G551S W1282X P5748 621 +1 G-T R352Q 1717-1G-T T3381 556delA Adapted from Ref 20 with permission recently described mutations [G85E and 278+5G-÷AI are less clearly determinant with respect to the pancreatic sufficient and pancreatic insufficient phenotypes. Login to comment
168 ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9709387:168:52
status: NEW
view ABCC7 p.Gly542* details
An early study suggested that the nonsense mutation G542X is associated with an increased risk of meconium ileus, but this association has not been confirmed in a study of larger patient cohort. Login to comment
169 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9709387:169:124
status: NEW
view ABCC7 p.Gly551Asp details
The CF genotype-phenotype consortium has reported a lower incidence of meconium ileus among compound heterozygotes carrying G551D/JIF508 (6.4%) in comparison with 19.5% in patients homozygous for JF50824. Login to comment